Showing results (1-10 of 320) with videos related to
Sort By:
Pageof 32
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Targeted Therapy in Chronic Lymphocytic LeukemiaThomas J Kipps, Michael Y ChoiCancer Journal (Sudbury, Mass.)|September 26, 2012
Inhibitors of B-cell receptor signaling for patients with B-cell malignanciesMichael Y Choi, Thomas J KippsCancers|December 23, 2022
Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter's SyndromeBenjamin M Heyman, Michael Y Choi, Thomas J KippsClinical Lymphoma, Myeloma & Leukemia|June 18, 2019
SOHO State of the Art Updates and Next Questions: The Conundrum in Assessing the Therapy Response of Patients With Chronic Lymphocytic LeukemiaMichael Y Choi, Huan-You Wang, Thomas J KippsCancer Research Communications|May 6, 2026
Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective AnalysisNirja N Shah, Tulsi Patel, Thomas J Kipps, et al.Leukemia|July 24, 2024
Mutation in Bruton Tyrosine Kinase (BTK) A428D confers resistance To BTK-degrader therapy in chronic lymphocytic leukemiaRichard L Wong, Michael Y Choi, Huan-You Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|July 27, 2011
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cellsDesheng Lu, Michael Y Choi, Jian Yu, et al.Cancer Journal (Sudbury, Mass.)|August 16, 2021
Mining the Microenvironment for Therapeutic Targets in Chronic Lymphocytic LeukemiaThomas J KippsSeminars in Oncology|February 14, 2002
Advances in classification and therapy of indolent B-cell malignanciesThomas J KippsSeminars in Oncology|February 1, 2017
Advances in classification and therapy of indolent B-cell malignanciesThomas J KippsPageof 32